| USD millions | FY2023 | FY2025 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|
| Revenue | 159.8 | 254.9 | 387.6 | 586.5 | +51.3% | |
| Cost of revenue | 11.6 | 6.5 | 6.7 | 14.1 | +109.4% | |
| Gross profit | 148.1 | 242.9 | 380.9 | 570.6 | +49.8% | |
| Research & development | — | — | 0.0 | — | — | |
| Selling, general & administrative | — | — | 269.0 | — | — | |
| Selling & marketing | — | — | 229.3 | — | — | |
| Operating expenses | — | 206.2 | 308.0 | — | — | |
| Operating income | (2.9) | 48.7 | 72.9 | (103.7) | −242.1% | |
| Interest expense | — | — | 3.2 | — | — | |
| Interest income | 5.8 | 5.6 | 5.8 | — | — | |
| Other income / expense | — | — | 2.8 | — | — | |
| Pre-tax income | 2.3 | 53.9 | 75.7 | (100.4) | −232.5% | |
| Income tax | 0.6 | 5.1 | 4.6 | 6.1 | +32.0% | |
| Net income | 1.7 | 48.8 | 71.2 | (106.4) | −249.6% | |
| Discontinued operations | — | — | 0.0 | — | — | |
| Other net income adjustments | — | — | 0.0 | — | — | |
| EPS, basic (per share) | 0.03 | 3.05 | 1.14 | (2.62) | −329.5% | |
| EPS, diluted (per share) | 0.03 | 0.85 | 1.14 | (2.63) | −330.4% | |
| EBITDA | 2.8 | 54.2 | 85.2 | (96.0) | −212.7% | |
| Depreciation & amortization | 5.7 | 5.4 | 6.3 | 6.3 | −0.0% | |
| Weighted average shares (shares) | 62,869,653 | 16,007,000 | 62,558,380 | — | — | |
| Weighted average diluted shares (shares) | 62,869,653 | 57,600,000 | 62,558,380 | — | — | |
| Gross margin | 92.7% | 95.3% | 98.3% | 97.3% | −1.0 pts | |
| Operating margin | −1.8% | 19.1% | 18.8% | −17.7% | −36.5 pts | |
| Net margin | 1.1% | 19.2% | 18.4% | −18.1% | −36.5 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
